Mechanistic biomarkers for autism treatment
Related Experiment Video
Updated: Jun 21, 2026
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
Robert L Hendren1, Kiah Bertoglio, Paul Ashwood
1Department of Psychiatry, University of California, San Francisco, 401 Parnassus Ave, Box F-0984, San Francisco, CA 94143-0984, USA. Robert.Hendren@ucsf.edu
Objective:
Autism is a syndrome with a number of etiologies with differing mechanisms that lead to abnormal development. This review highlights the need to identify autism subgroups as they each might require unique approaches for prevention or treatment.
Methods:
Targeting treatments to specific mechanisms and utilizing biomarkers can more rapidly advance our understanding of how to classify and treat autism subgroups based on translational mechanisms. We illustrate this approach using mechanisms that may influence the course of autism and provide rationale for selected biomarkers that could guide treatments targeted anywhere from DNA to symptom expression.
Conclusions:
The use of potential biomarkers that point to specific mechanisms of disordered neurodevelopment will help identify meaningful subtypes of autism and will help tailor treatment or prevention strategies for each mechanism rather than solely to a symptom category.
Insights
Identifying autism subgroups through specific mechanisms and biomarkers is crucial. This approach enables tailored prevention and treatment strategies for more effective outcomes in autism spectrum disorder.
Area of Science:
- Neurodevelopmental disorders
- Autism spectrum disorder (ASD) research
- Translational neuroscience
Background:
- Autism is a complex syndrome with diverse etiologies and developmental mechanisms.
- Current approaches to autism prevention and treatment may not be universally effective due to heterogeneity.
- There is a critical need to identify distinct autism subgroups for personalized interventions.
Purpose of the Study:
- To emphasize the importance of classifying autism into subgroups based on underlying biological mechanisms.
- To advocate for the use of biomarkers to guide the development of targeted treatments for autism.
- To illustrate how a mechanism-based approach can advance autism research and clinical practice.
Main Methods:
- Reviewing mechanisms influencing autism development and progression.
- Identifying and providing rationale for selected biomarkers.
- Linking biomarkers to specific neurodevelopmental pathways relevant to autism.
- Illustrating a translational approach from molecular mechanisms to clinical expression.
Main Results:
- Autism heterogeneity necessitates subgroup identification for effective management.
- Biomarkers can elucidate specific etiological mechanisms in autism.
- Targeting treatments to identified mechanisms can improve therapeutic efficacy.
- A mechanism-based classification system offers a more precise approach to autism subtypes.
Conclusions:
- Biomarkers are essential for identifying meaningful autism subtypes based on neurodevelopmental mechanisms.
- Tailoring treatment and prevention strategies to specific mechanisms, rather than broad symptom categories, is key.
- This approach promises more precise and effective interventions for individuals with autism spectrum disorder.
Related Concept Videos
01:19Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:26Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...